checkAd

     591  0 Kommentare Xylem reports third quarter earnings growth and margin expansion

    Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, today reported third quarter 2019 net income of $65 million, or $0.36 per share. Excluding the impact of restructuring and realignment, impairment charges and one-time tax benefits, the Company delivered adjusted net income of $149 million, or $0.82 per share in the quarter. Excluding the impact of foreign exchange translation, adjusted earnings per share was up 10 percent. Third quarter revenue was $1.3 billion, up 3 percent organically led by healthy growth in the utilities end-market moderated by slower-than-expected growth in industrial and commercial markets. Reported operating margin in the quarter was 0.8 percent and adjusted operating margin was 15.1 percent, up 50 basis points compared to the prior year.

    “Solid demand and disciplined execution in our largest markets drove margin expansion and delivery on our earnings commitments," said Patrick Decker, president and CEO of Xylem. "Steady revenue growth in our utilities business has been partially offset, however, by notable weakening in industrial and commercial end-markets.”

    “The near-term softness in those market environments has caused us to lower our organic revenue and earnings guidance," Decker continued. "Nevertheless, we expect to exit the year with sizable backlogs as our core utilities business remains healthy and the digital transformation of the water sector continues to gather pace. This gives us confidence in our ability to continue to outperform the market in 2020, and deliver mid-single-digit growth over the long term."

    Full-year 2019 Outlook

    Xylem is updating its forecasted full-year 2019 revenue outlook to be in the range of $5.24 to $5.27 billion. On an organic basis, Xylem’s revenue growth is adjusted to a range of 3 to 4 percent (approximately 1 percent on a reported basis) from previous guidance of 5 to 6 percent.

    Xylem is revising its full-year 2019 adjusted operating margin outlook from 14.5 to 14.9 percent to 13.8 to 14.0 percent. The full-year adjusted earnings per share is now expected to be $3.01 to $3.03, lowered from previous guidance of $3.12 to $3.22, but reflecting an increase of approximately 5 percent versus prior year — the equivalent of 7 to 8 percent excluding foreign exchange effects. The Company’s adjusted earnings outlook excludes projected restructuring and realignment and goodwill impairment costs. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort.

    Third Quarter Segment Results

    Water Infrastructure

    Xylem’s Water Infrastructure segment consists of its portfolio of businesses primarily serving wastewater operations for utility and industrial customers through transport, dewatering and treatment applications.

    • Third quarter 2019 revenue was $531 million, up 1 percent organically compared with third quarter 2018. Healthy growth in the utilities market, particularly in the U.S., more than offset declines in our short-cycle industrial business.
    • Third quarter reported operating income for the segment was $97 million and adjusted operating income, which excludes $7 million of restructuring and realignment costs, was $104 million. The segment’s reported operating margin was 18.3 percent and adjusted operating margin was 19.6 percent, up 40 basis points versus the prior year due to higher net productivity and price realization, partially offset by the impact of lower volumes and mix.

    Applied Water

    Xylem’s Applied Water segment consists of its portfolio of businesses primarily serving the end users of water through industrial water management, commercial building services and residential applications.

    • Third quarter 2019 Applied Water revenue was $376 million, a 1 percent increase organically year-over-year. Versus strong prior year comparisons, both industrial and commercial end-markets were slower than expected, influenced by U.S. project delays.
    • Third quarter reported operating income for the segment was $61 million and adjusted operating income, which excludes $3 million of restructuring and realignment costs, was $64 million. The segment’s reported operating margin was 16.2 percent and adjusted operating margin was 17.0 percent, an 90 basis point increase over prior year period due to higher price realization and productivity more than off-setting inflation.

    Measurement & Control Solutions

    Xylem’s Measurement & Control Solutions segment consists of its portfolio of businesses primarily serving the clean water and energy operations for utility and industrial customers through smart metering, network technologies, advanced infrastructure analytics and analytic instrumentation applications.

    • Third quarter 2019 Measurement & Control Solutions revenue was $389 million, up 8 percent organically versus the prior year. Revenue growth was driven by execution in the metrology water business.
    • Third quarter reported operating income for the segment was a loss of $136 million, and adjusted operating income, which excludes $20 million of restructuring and realignment costs and a $155 million impairment charge, was $39 million. The segment’s reported operating margin was -35 percent. Adjusted operating margin was 10 percent, up 50 basis points versus the prior year, driven by productivity and volume gains, as well as increased price realization, which was partially offset by higher growth investments.

    Supplemental information on Xylem’s third quarter 2019 earnings and reconciliations for certain non-GAAP items is posted at www.xylem.com/investors.

    About Xylem

    Xylem (XYL) is a leading global water technology company committed to developing innovative technology solutions to the world’s water challenges. The Company’s products and services move, treat, analyze, monitor and return water to the environment in public utility, industrial, residential and commercial building services settings. Xylem also provides a leading portfolio of smart metering, network technologies and advanced infrastructure analytics solutions for water, electric and gas utilities. The Company’s approximately 17,000 employees bring broad applications expertise with a strong focus on identifying comprehensive, sustainable solutions. Headquartered in Rye Brook, New York, with 2018 revenue of $5.2 billion, Xylem does business in more than 150 countries through a number of market-leading product brands.

    The name Xylem is derived from classical Greek and is the tissue that transports water in plants, highlighting the engineering efficiency of our water-centric business by linking it with the best water transportation of all – that which occurs in nature. For more information, please visit us at www.xylem.com.

    Forward-Looking Statements

    This press release contains information that may constitute “forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Generally, the words “anticipate,” “estimate,” “expect,” “project,” “intend,” “plan,” “forecast,” “believe,” “target,” “will,” “could,” “would,” “should” and similar expressions identify forward-looking statements. However, the absence of these words or similar expressions does not mean that a statement is not forward-looking. These forward-looking statements include any statements that are not historical in nature, including any statements about the capitalization of the Company, the Company’s restructuring and realignment, future strategic plans and other statements that describe the Company’s business strategy, outlook, objectives, plans, intentions or goals. All statements that address operating or financial performance, events or developments that we expect or anticipate will occur in the future - including statements relating to orders, revenues, operating margins and earnings per share growth, and statements expressing general views about future operating results - are forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from those expressed or implied in, or reasonably inferred from, such forward-looking statements.

    Factors that could cause results to differ materially from those anticipated include: overall economic and business conditions, political and other risks associated with our international operations, including military actions, economic sanctions or trade barriers including tariffs and embargoes that could affect customer markets and our business, and non-compliance with laws, including foreign corrupt practice laws, data privacy, export and import laws and competition laws; potential for unexpected cancellations or delays of customer orders in our reported backlog; our exposure to fluctuations in foreign currency exchange rates; competition and pricing pressures in the markets we serve; the strength of housing and related markets; weather conditions; ability to retain and attract talent and key members of management; our relationship with and the performance of our channel partners; our ability to successfully identify, complete and integrate acquisitions; our ability to borrow or to refinance our existing indebtedness and availability of liquidity sufficient to meet our needs; uncertainty from the expected discontinuance of LIBOR and transition to any other interest rate benchmark; changes in the value of goodwill or intangible assets; risks relating to product defects, product liability and recalls; claims or investigations by governmental or regulatory bodies; security breaches or other disruptions of our information technology systems; litigation and contingent liabilities; and other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2018 ("2018 Annual Report") and with subsequent filings we make with the Securities and Exchange Commission ("SEC").

    All forward-looking statements made herein are based on information currently available to the Company as of the date of this Report. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

    ###

    XYLEM INC. AND SUBSIDIARIES
    CONDENSED CONSOLIDATED INCOME STATEMENTS (Unaudited)
    (in millions, except per share data)

     

    Three Months

     

    Nine Months

    For the periods ended September 30,

    2019

     

    2018

     

    2019

     

    2018

    Revenue

    $

    1,296

     

     

    $

    1,287

     

     

    $

    3,878

     

     

    $

    3,821

     

    Cost of revenue

    787

     

     

    782

     

     

    2,369

     

     

    2,337

     

    Gross profit

    509

     

     

    505

     

     

    1,509

     

     

    1,484

     

    Selling, general and administrative expenses

    273

     

     

    279

     

     

    870

     

     

    868

     

    Research and development expenses

    44

     

     

    46

     

     

    142

     

     

    137

     

    Restructuring and asset impairment charges

    33

     

     

    4

     

     

    58

     

     

    19

     

    Goodwill impairment charge

    148

     

     

     

     

    148

     

     

     

    Operating income

    11

     

     

    176

     

     

    291

     

     

    460

     

    Interest expense

    16

     

     

    21

     

     

    52

     

     

    63

     

    Other non-operating (expense) income, net

    (7

    )

     

    4

     

     

    (2

    )

     

    9

     

    Gain from sale of business

     

     

    2

     

     

    1

     

     

     

    (Loss) income before taxes

    (12

    )

     

    161

     

     

    238

     

     

    406

     

    Income tax (benefit) expense

    (77

    )

     

    31

     

     

    (45

    )

     

    82

     

    Net income

    $

    65

     

     

    $

    130

     

     

    $

    283

     

     

    $

    324

     

    Earnings per share:

     

     

     

     

     

     

     

    Basic

    $

    0.36

     

     

    $

    0.73

     

     

    $

    1.57

     

     

    $

    1.80

     

    Diluted

    $

    0.36

     

     

    $

    0.72

     

     

    $

    1.56

     

     

    $

    1.79

     

    Weighted average number of shares:

     

     

     

     

     

     

     

    Basic

    180.1

     

     

    179.7

     

     

    179.9

     

     

    179.8

     

    Diluted

    181.2

     

     

    181.1

     

     

    181.2

     

     

    181.2

     

    XYLEM INC. AND SUBSIDIARIES
    CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
    (in millions, except per share amounts)

     

    September 30,
    2019

     

    December 31,
    2018

     

     

     

     

    ASSETS

     

     

     

    Current assets:

     

     

     

    Cash and cash equivalents

    $

    453

     

     

    $

    296

     

    Receivables, less allowances for discounts and doubtful accounts of $33 and $35 in 2019 and 2018, respectively

    1,078

     

     

    1,031

     

    Inventories

    580

     

     

    595

     

    Prepaid and other current assets

    152

     

     

    172

     

    Total current assets

    2,263

     

     

    2,094

     

    Property, plant and equipment, net

    641

     

     

    656

     

    Goodwill

    2,811

     

     

    2,976

     

    Other intangible assets, net

    1,180

     

     

    1,232

     

    Other non-current assets

    620

     

     

    264

     

    Total assets

    $

    7,515

     

     

    $

    7,222

     

    LIABILITIES AND STOCKHOLDERS’ EQUITY

     

     

     

    Current liabilities:

     

     

     

    Accounts payable

    $

    521

     

     

    $

    586

     

    Accrued and other current liabilities

    634

     

     

    546

     

    Short-term borrowings and current maturities of long-term debt

    306

     

     

    257

     

    Total current liabilities

    1,461

     

     

    1,389

     

    Long-term debt

    2,030

     

     

    2,051

     

    Accrued postretirement benefits

    385

     

     

    400

     

    Deferred income tax liabilities

    310

     

     

    303

     

    Other non-current accrued liabilities

    434

     

     

    297

     

    Total liabilities

    4,620

     

     

    4,440

     

     

     

     

     

    Stockholders’ equity:

     

     

     

    Common Stock – par value $0.01 per share:

     

     

     

    Authorized 750.0 shares, issued 193.8 shares and 192.9 shares in 2019 and 2018, respectively

    2

     

     

    2

     

    Capital in excess of par value

    1,983

     

     

    1,950

     

    Retained earnings

    1,791

     

     

    1,639

     

    Treasury stock – at cost 13.7 shares and 13.2 shares in 2019 and 2018, respectively

    (526

    )

     

    (487

    )

    Accumulated other comprehensive loss

    (364

    )

     

    (336

    )

    Total stockholders’ equity

    2,886

     

     

    2,768

     

    Non-controlling interests

    9

     

     

    14

     

    Total equity

    2,895

     

     

    2,782

     

    Total liabilities and stockholders’ equity

    $

    7,515

     

     

    $

    7,222

     

    XYLEM INC. AND SUBSIDIARIES
    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
    (in millions)

    For the nine months ended September 30,

    2019

     

    2018

    Operating Activities

     

     

     

    Net income

    $

    283

     

     

    $

    324

     

    Adjustments to reconcile net income to net cash provided by operating activities:

     

     

     

    Depreciation

    88

     

     

    87

     

    Amortization

    104

     

     

    108

     

    Share-based compensation

    23

     

     

    23

     

    Restructuring and asset impairment charges

    58

     

     

    19

     

    Goodwill impairment charge

    148

     

     

     

    Gain from sale of business

    (1

    )

     

     

    Other, net

    7

     

     

    2

     

    Payments for restructuring

    (21

    )

     

    (18

    )

    Changes in assets and liabilities (net of acquisitions):

     

     

     

    Changes in receivables

    (73

    )

     

    (76

    )

    Changes in inventories

    (2

    )

     

    (115

    )

    Changes in accounts payable

    (30

    )

     

    51

     

    Changes in accrued taxes

    (140

    )

     

    20

     

    Other, net

    7

     

     

    (37

    )

    Net Cash – Operating activities

    451

     

     

    388

     

    Investing Activities

     

     

     

    Capital expenditures

    (175

    )

     

    (171

    )

    Acquisitions of businesses, net of cash acquired

    (18

    )

     

    (433

    )

    Proceeds from sale of business

    (2

    )

     

    22

     

    Cash received from investments

    3

     

     

     

    Other, net

    7

     

     

    3

     

    Net Cash – Investing activities

    (185

    )

     

    (579

    )

    Financing Activities

     

     

     

    Short-term debt issued, net

    317

     

     

    410

     

    Short-term debt repaid

    (254

    )

     

    (50

    )

    Repurchase of common stock

    (39

    )

     

    (58

    )

    Proceeds from exercise of employee stock options

    10

     

     

    7

     

    Dividends paid

    (131

    )

     

    (114

    )

    Other, net

    (2

    )

     

     

    Net Cash – Financing activities

    (99

    )

     

    195

     

    Effect of exchange rate changes on cash

    (10

    )

     

    (14

    )

    Net change in cash and cash equivalents

    157

     

     

    (10

    )

    Cash and cash equivalents at beginning of year

    296

     

     

    414

     

    Cash and cash equivalents at end of period

    $

    453

     

     

    $

    404

     

    Supplemental disclosure of cash flow information:

     

     

     

    Cash paid during the period for:

     

     

     

    Interest

    $

    46

     

     

    $

    47

     

    Income taxes (net of refunds received)

    $

    94

     

     

    $

    60

     

    Xylem Inc. Non-GAAP Measures

    Management reviews key performance indicators including revenue, gross margins, segment operating income and margins, orders growth, working capital and backlog, among others. In addition, we consider certain non-GAAP (or "adjusted") measures to be useful to management and investors evaluating our operating performance for the periods presented, and to provide a tool for evaluating our ongoing operations, liquidity and management of assets. This information can assist investors in assessing our financial performance and measures our ability to generate capital for deployment among competing strategic alternatives and initiatives, including but not limited to, dividends, acquisitions, share repurchases and debt repayment. Excluding revenue, Xylem provides guidance only on a non-GAAP basis due to the inherent difficulty in forecasting certain amounts that would be included in GAAP earnings, such as discrete tax items, without unreasonable effort. These adjusted metrics are consistent with how management views our business and are used to make financial, operating and planning decisions. These metrics, however, are not measures of financial performance under GAAP and should not be considered a substitute for revenue, operating income, net income, earnings per share (basic and diluted) or net cash from operating activities as determined in accordance with GAAP. We consider the following non-GAAP measures, which may not be comparable to similarly titled measures reported by other companies, to be key performance indicators:

    “Organic revenue" and "Organic orders” defined as revenue and orders, respectively, excluding the impact of fluctuations in foreign currency translation and contributions from acquisitions and divestitures. Divestitures include sales of insignificant portions of our business that did not meet the criteria for classification as a discontinued operation. The period-over-period change resulting from foreign currency translation impacts is determined by translating current period and prior period activity using the same currency conversion rate.

    “Constant currency” defined as financial results adjusted for foreign currency translation impacts by translating current period and prior period activity using the same currency conversion rate. This approach is used for countries whose functional currency is not the U.S. dollar.

    “EBITDA” defined as earnings before interest, taxes, depreciation and amortization expense. “Adjusted EBITDA” reflects the adjustment to EBITDA to exclude share-based compensation charges, restructuring and realignment costs, gain or loss from sale of businesses and special charges.

    "Adjusted Operating Income", "Adjusted Segment Operating Income", "Adjusted Net Income" and “Adjusted EPS” defined as operating income, segment operating income, net income and earnings per share, adjusted to exclude restructuring and realignment costs, gain or loss from sale of businesses, special charges and tax-related special items, as applicable.

    “Free Cash Flow” defined as net cash from operating activities, as reported in the Statement of Cash Flow, less capital expenditures as well as adjustments for other significant items that impact current results which management believes are not related to our ongoing operations and performance. Our definition of "free cash flow" does not consider certain non-discretionary cash payments, such as debt.

    “Realignment costs” defined as costs not included in restructuring costs that are incurred as part of actions taken to reposition our business, including items such as professional fees, severance, relocation, travel, facility set-up and other costs.

    “Sensus Acquisition Related Costs” defined as costs incurred by the Company associated with the acquisition of Sensus that are being reported within operating income. These costs include integration costs, acquisition costs, costs related to the recognition of the backlog intangible asset amortization recorded in purchase accounting.

    “Special charges" defined as costs incurred by the Company, such as acquisition and integration related costs not included in "Sensus Acquisition Related Costs", non-cash impairment charges and other special non-operating items, such as pension adjustments.

    “Tax-related special items" defined as tax items, such as tax return versus tax provision adjustments, tax exam impacts, tax law change impacts, significant reserves for cash repatriation, excess tax benefits/losses and other discrete tax adjustments.

    Reported vs. Organic & Constant Currency Orders
    ($ Millions)

     
    (As Reported - GAAP) (As Adjusted - Organic) Constant Currency
    (A) (B) (C) (D) (E) = B+C+D (F) = E/A (G) = (E - C) / A
     
    Change % Change Acquisitions /
    Divestitures
    Change % Change
    Orders Orders 2019 v. 2018 2019 v. 2018 FX Impact Adj. 2019 v. 2018 Adj. 2019 v. 2018

    2019

    2018

    Nine Months Ended September 30
     
    Xylem Inc.

    4,053

    4,054

    (1)

    0%

    13

    113

    125

    3%

    3%

     
    Water Infrastructure

    1,704

    1,671

    33

    2%

    -

    64

    97

    6%

    6%

    Applied Water

    1,169

    1,162

    7

    1%

    -

    26

    33

    3%

    3%

    Measurement & Control Solutions

    1,180

    1,221

    (41)

    -3%

    13

    23

    (5)

    0%

    -1%

     
    Quarter Ended September 30
     
    Xylem Inc.

    1,346

    1,356

    (10)

    -1%

    4

    24

    18

    1%

    1%

     
    Water Infrastructure

    586

    537

    49

    9%

    -

    13

    62

    12%

    12%

    Applied Water

    376

    377

    (1)

    0%

    -

    6

    5

    1%

    1%

    Measurement & Control Solutions

    384

    442

    (58)

    -13%

    4

    5

    (49)

    -11%

    -12%

     
    Quarter Ended June 30
     
    Xylem Inc.

    1,392

    1,378

    14

    1%

    7

    33

    54

    4%

    3%

     
    Water Infrastructure

    586

    580

    6

    1%

    -

    16

    22

    4%

    4%

    Applied Water

    399

    401

    (2)

    0%

    -

    8

    6

    1%

    1%

    Measurement & Control Solutions

    407

    397

    10

    3%

    7

    9

    26

    7%

    5%

     
    Quarter Ended March 31
     
    Xylem Inc.

    1,315

    1,320

    (5)

    0%

    2

    56

    53

    4%

    4%

     
    Water Infrastructure

    532

    554

    (22)

    -4%

    -

    35

    13

    2%

    2%

    Applied Water

    394

    384

    10

    3%

    -

    12

    22

    6%

    6%

    Measurement & Control Solutions

    389

    382

    7

    2%

    2

    9

    18

    5%

    4%

    Xylem Inc. Non-GAAP Reconciliation
    Reported vs. Organic & Constant Currency Revenue
    ($ Millions)

    (As Reported - GAAP) (As Adjusted - Organic) Constant Currency
    (A) (B) (C) (D) (E) = B+C+D (F) = E/A (G) = (E - C) / A
     
    Change % Change Acquisitions /
    Divestitures
    Change % Change
    Revenue Revenue 2019 v. 2018 2019 v. 2018 FX Impact Adj. 2019 v. 2018 Adj. 2019 v. 2018

    2019

    2018

    Nine Months Ended September 30
     
    Xylem Inc.

    3,878

    3,821

    57

    1%

    18

    107

    182

    5%

    4%

     
    Water Infrastructure

    1,574

    1,567

    7

    0%

    -

    59

    66

    4%

    4%

    Applied Water

    1,149

    1,132

    17

    2%

    -

    26

    43

    4%

    4%

    Measurement & Control Solutions

    1,155

    1,122

    33

    3%

    18

    22

    73

    7%

    5%

     
    Quarter Ended September 30
     
    Xylem Inc.

    1,296

    1,287

    9

    1%

    4

    24

    37

    3%

    3%

     
    Water Infrastructure

    531

    541

    (10)

    -2%

    -

    13

    3

    1%

    1%

    Applied Water

    376

    378

    (2)

    -1%

    -

    6

    4

    1%

    1%

    Measurement & Control Solutions

    389

    368

    21

    6%

    4

    5

    30

    8%

    7%

     
    Quarter Ended June 30
     
    Xylem Inc.

    1,345

    1,317

    28

    2%

    9

    32

    69

    5%

    5%

     
    Water Infrastructure

    561

    546

    15

    3%

    -

    16

    31

    6%

    6%

    Applied Water

    394

    388

    6

    2%

    -

    8

    14

    4%

    4%

    Measurement & Control Solutions

    390

    383

    7

    2%

    9

    8

    24

    6%

    4%

     
    Quarter Ended March 31
     
    Xylem Inc.

    1,237

    1,217

    20

    2%

    5

    51

    76

    6%

    6%

     
    Water Infrastructure

    482

    480

    2

    0%

    -

    30

    32

    7%

    7%

    Applied Water

    379

    366

    13

    4%

    -

    12

    25

    7%

    7%

    Measurement & Control Solutions

    376

    371

    5

    1%

    5

    9

    19

    5%

    4%

    Xylem Inc. Non-GAAP Reconciliation
    Adjusted Operating Income
    ($ Millions)

    Q1 Q2 Q3 YTD

    2019

    2018

    2019

    2018

    2019

    2018

    2019

    2018

    Total Revenue
    • Total Xylem

    1,237

    1,217

    1,345

    1,317

    1,296

    1,287

    3,878

    3,821

    • Water Infrastructure

    482

    480

    561

    546

    531

    541

    1,574

    1,567

    • Applied Water

    379

    366

    394

    388

    376

    378

    1,149

    1,132

    • Measurement & Control Solutions

    376

    371

    390

    383

    389

    368

    1,155

    1,122

     
    Operating Income
    • Total Xylem

    109

    113

    171

    171

    11

    176

    291

    460

    • Water Infrastructure

    51

    49

    98

    92

    97

    99

    246

    240

    • Applied Water

    56

    50

    62

    61

    61

    59

    179

    170

    • Measurement & Control Solutions

    16

    33

    26

    31

    (136)

    31

    (94)

    95

    • Total Segments

    123

    132

    186

    184

    22

    189

    331

    505

     
    Operating Margin
    • Total Xylem

    8.8%

    9.3%

    12.7%

    13.0%

    0.8%

    13.7%

    7.5%

    12.0%

    • Water Infrastructure

    10.6%

    10.2%

    17.5%

    16.8%

    18.3%

    18.3%

    15.6%

    15.3%

    • Applied Water

    14.8%

    13.7%

    15.7%

    15.7%

    16.2%

    15.6%

    15.6%

    15.0%

    • Measurement & Control Solutions

    4.3%

    8.9%

    6.7%

    8.1%

    -35.0%

    8.4%

    -8.1%

    8.5%

    • Total Segments

    9.9%

    10.8%

    13.8%

    14.0%

    1.7%

    14.7%

    8.5%

    13.2%

     
    Special Charges
    • Total Xylem

    4

    6

    -

    1

    155

    1

    159

    8

    • Water Infrastructure

    -

    -

    -

    -

    -

    -

    -

    -

    • Applied Water

    -

    -

    -

    -

    -

    -

    -

    -

    • Measurement & Control Solutions

    4

    2

    -

    1

    155

    -

    159

    3

    • Total Segments

    4

    2

    -

    1

    155

    -

    159

    3

     
    Restructuring & Realignment Costs
    • Total Xylem

    20

    16

    21

    10

    30

    11

    71

    37

    • Water Infrastructure

    9

    5

    9

    5

    7

    5

    25

    15

    • Applied Water

    3

    3

    4

    2

    3

    2

    10

    7

    • Measurement & Control Solutions

    8

    8

    8

    3

    20

    4

    36

    15

    • Total Segments

    20

    16

    21

    10

    30

    11

    71

    37

     
    Adjusted Operating Income
    • Total Xylem

    133

    135

    192

    182

    196

    188

    521

    505

    • Water Infrastructure

    60

    54

    107

    97

    104

    104

    271

    255

    • Applied Water

    59

    53

    66

    63

    64

    61

    189

    177

    • Measurement & Control Solutions

    28

    43

    34

    35

    39

    35

    101

    113

    • Total Segments

    147

    150

    207

    195

    207

    200

    561

    545

     
    Adjusted Operating Margin
    • Total Xylem

    10.8%

    11.1%

    14.3%

    13.8%

    15.1%

    14.6%

    13.4%

    13.2%

    • Water Infrastructure

    12.4%

    11.3%

    19.1%

    17.8%

    19.6%

    19.2%

    17.2%

    16.3%

    • Applied Water

    15.6%

    14.5%

    16.8%

    16.2%

    17.0%

    16.1%

    16.4%

    15.6%

    • Measurement & Control Solutions

    7.4%

    11.6%

    8.7%

    9.1%

    10.0%

    9.5%

    8.7%

    10.1%

    • Total Segments

    11.9%

    12.3%

    15.4%

    14.8%

    16.0%

    15.5%

    14.5%

    14.3%

    Xylem Inc. Non-GAAP Reconciliation
    Adjusted Diluted EPS
    ($ Millions, except per share amounts)

    Q3 2019 Q3 2018
    As Reported Adjustments Adjusted As Reported Adjustments Adjusted
    Total Revenue

    1,296

    -

    1,296

    1,287

    -

    1,287

    Operating Income

    11

    185

    a

    196

    176

    12

    a

    188

    Operating Margin

    0.8%

    15.1%

    13.7%

    14.6%

    Interest Expense

    (16)

    -

    (16)

    (21)

    -

    (21)

    Other Non-Operating Income (Expense)

    (7)

    11

    b

    4

    4

    -

    4

    Gain/(Loss) From Sale of Businesses

    -

    -

    -

    2

    (2)

    -

    Income before Taxes

    (12)

    196

    184

    161

    10

    171

    Provision for Income Taxes

    77

    (112)

    c

    (35)

    (31)

    (1)

    c

    (32)

    Net Income Attributable to Xylem

    65

    84

    149

    130

    9

    139

    Diluted Shares

    181.2

    181.2

    181.1

    181.1

    Diluted EPS

    $ 0.36

    $ 0.46

    $ 0.82

    $ 0.72

    $ 0.05

    $ 0.77

     
    Year-over-year currency translation impact on current year diluted EPS

    $ (0.02)

    $ (0.01)

    $ (0.03)

    Diluted EPS at Constant Currency

    $ 0.38

    $ 0.47

    $ 0.85

     
     
     
    Q3 YTD 2019 Q3 YTD 2018

    As Reported

    Adjustments

    Adjusted

    As Reported

    Adjustments

    Adjusted

    Total Revenue

    3,878

    -

    3,878

    3,821

    3,821

    Operating Income

    291

    230

    a

    521

    460

    45

    a

    505

    Operating Margin

    7.5%

    13.4%

    12.0%

    13.2%

    Interest Expense

    (52)

    -

    (52)

    (63)

    -

    (63)

    Other Non-Operating Income (Expense)

    (2)

    11

    b

    9

    9

    -

    9

    Gain/(Loss) From Sale of Businesses

    1

    (1)

    -

    -

    -

    -

    Income before Taxes

    238

    240

    478

    406

    45

    451

    Provision for Income Taxes

    45

    (137)

    c

    (92)

    (82)

    (6)

    c

    (88)

    Net Income Attributable to Xylem

    283

    103

    386

    324

    39

    363

    Diluted Shares

    181.2

    181.2

    181.2

    181.2

    Diluted EPS

    $ 1.56

    $ 0.57

    $ 2.13

    $ 1.79

    $ 0.21

    $ 2.00

     
    Year-over-year currency translation impact on current year diluted EPS

    $ (0.07)

    $ (0.02)

    $ (0.09)

    Diluted EPS at Constant Currency

    $ 1.63

    $ 0.59

    $ 2.22

    a Quarter: Restructuring & realignment costs of $30 million and $11 million in 2019 and 2018, respectively; special charges of $155 million of intangible asset and goodwill impairment in 2019 $1 million of acquisition related costs in 2018.
    Year-to-date: Restructuring & realignment costs of $71 million and $37 million in 2019 and 2018, respectively; special charges of $155 million of intangible asset and goodwill impairment and $4 million of acquisition related costs in 2019 and $8 million of acquisition related costs in 2018.
     
    b Special charges related to incremental pension costs as a result of the planned buyout of our UK pension plan.
     
    c Quarter: Net tax impact on restructuring & realignment costs of $9 million and $3 million in 2019 and 2018, respectively; $2 million of tax impact on special charges in 2019 and tax-related special items of $101 million negative impact from benefit adjustments in 2019 and $2 million positive impact from expense adjustments in 2018.
    Year-to-date: Net tax impact on restructuring & realignment costs of $17 million and $10 million in 2019 and 2018, respectively; $2 million and $1 million of tax impact on special charges in 2019 and 2018, respectively and tax-related special items of $118 million negative impact from benefit adjustments in 2019 and $5 million positive impact from expense adjustments in 2018.

    Xylem Inc. Non-GAAP Reconciliation
    Net Cash - Operating Activities vs. Free Cash Flow
    ($ Millions)

    Q1 Q2 Q3 Year-to-Date

    2019

    2018

    2019

    2018

    2019

    2018

    2019

    2018

     
    Net Cash - Operating Activities

    $ 83

    $ 63

    $ 123

    $ 138

    $ 245

    $ 187

    $ 451

    $ 388

     
    Capital Expenditures

    (69)

    (61)

    (60)

    (50)

    (46)

    (60)

    (175)

    (171)

     
    Free Cash Flow

    $ 14

    $ 2

    $ 63

    $ 88

    $ 199

    $ 127

    $ 276

    $ 217

     
    Cash paid for Sensus acquisition related costs

    -

    (1)

    -

    -

    -

    -

    -

    (1)

     
    Free Cash Flow, excluding Sensus Acquisition Related Costs

    $ 14

    $ 3

    $ 63

    $ 88

    $ 199

    $ 127

    $ 276

    $ 218

     
    Net Income

    79

    79

    139

    115

    65

    130

    283

    324

     
    Gain/(Loss) from sale of businesses

    1

    -

    -

    (2)

    -

    2

    1

    -

     
    Special Charges - non-cash impairment

    (3)

    -

    -

    -

    (155)

    -

    (158)

    -

     
    Significant deferred tax benefit/(charge)

    -

    -

    -

    -

    97

    -

    97

     
    Net Income, excluding gain on sale of businesses, non-cash impairment charges and significant deferred tax items

    $ 81

    $ 79

    $ 139

    $ 117

    $ 123

    $ 128

    $ 343

    $ 324

    `
    Free Cash Flow Conversion

    17%

    4%

    45%

    75%

    162%

    99%

    80%

    67%

     



    Diskutieren Sie über die enthaltenen Werte


    Business Wire (engl.)
    0 Follower
    Autor folgen

    Xylem reports third quarter earnings growth and margin expansion Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, today reported third quarter 2019 net income of $65 million, or $0.36 per share. Excluding the impact of restructuring …

    Schreibe Deinen Kommentar

    Disclaimer